Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.
Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Cold & Cough Remedies (Pharmacies) market in Pakistan is experiencing significant growth and development due to several factors.
Customer preferences: Customers in Pakistan are increasingly seeking over-the-counter cold and cough remedies from pharmacies to alleviate their symptoms. The convenience and accessibility of pharmacies make them a popular choice for consumers looking for quick relief. In addition, the affordability of these remedies compared to prescription medications also attracts customers.
Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Pakistan is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious about the potential side effects of conventional medications and are opting for natural alternatives. This has led to the introduction of a wide range of herbal and natural cold and cough remedies in pharmacies across the country. Another trend in the market is the growing demand for combination products that offer relief from multiple symptoms. Cold and cough remedies that provide relief from congestion, sore throat, and cough in a single product are gaining popularity among consumers. This trend is driven by the convenience and cost-effectiveness of using a single product for multiple symptoms.
Local special circumstances: Pakistan has a high prevalence of respiratory diseases, especially during the winter season. The cold and dry weather conditions make people more susceptible to cold and cough. This creates a significant demand for cold and cough remedies in pharmacies throughout the country. Additionally, the lack of access to healthcare facilities in remote areas further drives the reliance on pharmacies for healthcare needs, including cold and cough remedies.
Underlying macroeconomic factors: The growing population and increasing disposable income in Pakistan are contributing to the growth of the Cold & Cough Remedies (Pharmacies) market. As more people have the means to afford healthcare products, the demand for cold and cough remedies is expected to continue rising. Furthermore, the expansion of the retail sector and the increasing number of pharmacies across the country provide greater accessibility to these remedies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Pakistan is witnessing growth and development due to customer preferences for over-the-counter remedies, the demand for natural and combination products, local special circumstances such as weather conditions, and underlying macroeconomic factors such as population growth and increasing disposable income.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.